ANGILERI Francesca
Associate Professor and PI at CICLY, center for innovation in cancerology of Lyon, UCBL1_HCL
My research is committed to developing a 3D liver model to better understand the secondary effects of anticancer agents. By investigating the link between pharmaco-toxicity and genotype-phenotype interactions, this work aims to improve patient follow-up and advance personalized medical care.
Magdalena Kasendra
Director of Research and Development, Center for Stem Cell and Organoid Medicine (CuSTOM), Cincinnati Children’s Hospital Medical Center